← Back
Data updated: Mar 10, 2026
DAITO
Pharmaceuticals
DAITO is a generic drug manufacturer with 1 FDA-approved products.
2023
Since
1
Drugs
-
Trials
4
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
METHOTREXATE SODIUM 2025-07-03
Labeling
METHOTREXATE SODIUM 2024-11-29
Labeling
METHOTREXATE SODIUM 2024-06-03
METHOTREXATE SODIUM 2024-05-16
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2023-08-07
- Latest
- 2023-08-07
- Applications
- 1